7% GHK-Cu Accelerant: Water, tripeptide-1 (GHK), cupric chloride, phenoxyethanol
Body composition Unlike some peptides, GHK-CU protocols typically use fixed doses rather than weight-based calculations
(Outlines contraindications for niacin therapy, including active peptic ulcer disease, active liver disease with elevated enzymes, hypersensitivity to niacin, and arterial bleeding, as well as monitoring recommendations for blood pressure, glucose, uric acid, etc., due to niacins systemic effects)
It can upregulate and downregulate over 4,000 genes, and its copper binding properties also exert many positive effects [2]
Bounous G, Batist G, Gold P
203210, pubmed.ncbi.nlm.nih.gov/23892832/